Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y. Cheng

P029 Circulating MDSCs Derived From Small Cell Lung Cancer Patients Secrete TGF - Beta 1 and Play Roles in Angiogenesis

Journal of Thoracic Oncology

English

P110 Disparities of EGFR Mutations Between Biopsy and Rebiopsy in Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

P1.01-98 a Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients With Brain Metastases or Dose Reductions

Journal of Thoracic Oncology

English

P1.01-108 Management of Anlotinib-Related Adverse Events: Data From ALTER 0303

Journal of Thoracic Oncology

English

P3.01-01 Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients

Journal of Thoracic Oncology

English

MA10.08 Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC

Journal of Thoracic Oncology

English

P027 Efficacy and Safety of Bevacizumab Combined With Chemotherapy for Second - Line and Above in Non - Squamous Cell Lung Cancer

Journal of Thoracic Oncology

English

JCES 01.11 a Multicenter, Non-Interventional Study on Real World EGFR Testing and in Patients With IIIB/IV NSCLC in Northern China

Journal of Thoracic Oncology

English

P1.01-107 the Impact of Anlotinib on Quality of Life in Patients With Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)

Journal of Thoracic Oncology

English

P107 the Study of Relationship Between Tumor Burden (TMB) and Molecular Typing of Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y. Cheng

P029 Circulating MDSCs Derived From Small Cell Lung Cancer Patients Secrete TGF - Beta 1 and Play Roles in Angiogenesis

P110 Disparities of EGFR Mutations Between Biopsy and Rebiopsy in Non-Small Cell Lung Cancer Patients

P1.01-98 a Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients With Brain Metastases or Dose Reductions

P1.01-108 Management of Anlotinib-Related Adverse Events: Data From ALTER 0303

P3.01-01 Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients

MA10.08 Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC

P027 Efficacy and Safety of Bevacizumab Combined With Chemotherapy for Second - Line and Above in Non - Squamous Cell Lung Cancer

JCES 01.11 a Multicenter, Non-Interventional Study on Real World EGFR Testing and in Patients With IIIB/IV NSCLC in Northern China

P1.01-107 the Impact of Anlotinib on Quality of Life in Patients With Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)

P107 the Study of Relationship Between Tumor Burden (TMB) and Molecular Typing of Non-Small Cell Lung Cancer (NSCLC)